PTGS2 and autism: In addition, a small clinical trial reported symptom improvement in children with autism using celecoxib, a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug, which was administered as adjunctive treatment to risperidone [18].